BR112015003372A2 - composição de conjugado , e , uso de uma composição. - Google Patents

composição de conjugado , e , uso de uma composição.

Info

Publication number
BR112015003372A2
BR112015003372A2 BR112015003372A BR112015003372A BR112015003372A2 BR 112015003372 A2 BR112015003372 A2 BR 112015003372A2 BR 112015003372 A BR112015003372 A BR 112015003372A BR 112015003372 A BR112015003372 A BR 112015003372A BR 112015003372 A2 BR112015003372 A2 BR 112015003372A2
Authority
BR
Brazil
Prior art keywords
composition
conjugate
conjugate composition
Prior art date
Application number
BR112015003372A
Other languages
English (en)
Other versions
BR112015003372A8 (pt
Inventor
Kara Elodie
Decourtye Jérémy
Dupuy Laurence
Christine Maurel Maria
Original Assignee
Repropharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repropharm filed Critical Repropharm
Publication of BR112015003372A2 publication Critical patent/BR112015003372A2/pt
Publication of BR112015003372A8 publication Critical patent/BR112015003372A8/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
BR112015003372A 2012-08-13 2013-05-06 Composição de conjugado , e , uso de uma composição BR112015003372A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1257780A FR2994482B1 (fr) 2012-08-13 2012-08-13 Composition, procede et trousse de detection du pic preovulatoire de lh
PCT/FR2013/051013 WO2014027149A1 (fr) 2012-08-13 2013-05-06 Composition de conjugues et utilisations

Publications (2)

Publication Number Publication Date
BR112015003372A2 true BR112015003372A2 (pt) 2017-07-04
BR112015003372A8 BR112015003372A8 (pt) 2018-02-06

Family

ID=47827338

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015003372A BR112015003372A8 (pt) 2012-08-13 2013-05-06 Composição de conjugado , e , uso de uma composição

Country Status (6)

Country Link
US (1) US20150285825A1 (pt)
EP (1) EP2883049B1 (pt)
BR (1) BR112015003372A8 (pt)
CA (1) CA2881405A1 (pt)
FR (1) FR2994482B1 (pt)
WO (1) WO2014027149A1 (pt)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
FR2625099B1 (fr) * 1987-12-24 1991-06-14 Transgene Sa Proteines et leur procede de preparation, sequences d'adn, anticorps et leur application, poxvirus, cellules transformees ou infectees et compositions pharmaceutiques utiles dans la prevention de la toxoplasmose
US5173399A (en) * 1988-06-10 1992-12-22 Abbott Laboratories Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
US5116726A (en) * 1988-07-25 1992-05-26 Syntex (U.S.A.) Inc. Methods for removal of detergents from analytes
WO1991010138A1 (en) * 1989-12-27 1991-07-11 Baxter Diagnostics Inc. Method to immobilize cardiolipin, phosphatidyl choline and cholesterol to solid phase and immunoassay
RU2202798C2 (ru) * 2000-07-05 2003-04-20 Иркутский научно-исследовательский противочумный институт Сибири и Дальнего Востока Способ приготовления диагностикума для детекции противобруцеллезных антител в сыворотках крови методом дот-иммуноанализа
CN101097216A (zh) * 2007-06-18 2008-01-02 曹健荣 人类免疫缺陷病毒抗体确认试剂
CN101576559A (zh) * 2008-12-25 2009-11-11 浙江省海洋水产研究所 一种血卵涡鞭虫兔抗血清及其应用

Also Published As

Publication number Publication date
EP2883049A1 (fr) 2015-06-17
US20150285825A1 (en) 2015-10-08
BR112015003372A8 (pt) 2018-02-06
CA2881405A1 (fr) 2014-02-20
FR2994482B1 (fr) 2014-08-22
WO2014027149A1 (fr) 2014-02-20
EP2883049B1 (fr) 2017-05-31
FR2994482A1 (fr) 2014-02-14

Similar Documents

Publication Publication Date Title
BR112014031262A2 (pt) composições biocatalisadoras inovadoras e processos para uso.
BR112015000420A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112014029115A2 (pt) composto, composição farmacêutica, e, uso de um composto ou composição
BR112015002738A2 (pt) composto , e , composição farmacêutica
BR112014030278A2 (pt) anticorpo, e, composição.
BR112014031412A2 (pt) método de preparação de uma composição, composição e seu uso, e kit.
BR112014001255A2 (pt) composto, uso de um composto, combinação, e, composição farmacêutica
FR2962442B1 (fr) Composition stable de 2,3,3,3-tetrafluoropropene
BR112015003259A2 (pt) composto, composição farmacêutica, e, composição de vacina.
BR112013003536A2 (pt) composição, e utilização de uma composição.
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BR112014023200A2 (pt) uso de uma composição
CO6960553A2 (es) Fluorometil-5,6-dihidro-4h-[1,3]oxazinas
BR112015002824A2 (pt) composto, uso de um composto, composição farmacêutica, e, produto farmacêutico de combinação.
BR112014016635A8 (pt) composto, composição, e, uso de um composto
FR2955770B1 (fr) Composition cosmetique.
BR112013019327A2 (pt) composto, e, composição.
BR112014029642A2 (pt) composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit
BR112014026873A2 (pt) método cosmético, composição cosmética e uso.
BR112014010506A2 (pt) corda, e, uso de uma corda.
BR112014025416A2 (pt) AGENTES ANTIMALÁRICOS, COMPOSIÇÃO FARMACEUTICA COMPREENDENDO-OS E USO Dos MESMOS.
BR112014026397A2 (pt) composição e uso de uma composição
CL2015001458A1 (es) Composición simbiotica y el uso de la misma.
BR112013030897A2 (pt) composição.
BR112014028443A2 (pt) composição estéril.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: REPROPHARM VET (FR)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements